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Congenital malformations of the lung (CML) are rare with similar embryological and clinical spectra and could result in
mortality if left untreated. Bronchogenic cysts are formed during the budding of the tracheal diverticula and ventral foregut in the
embryological period. In this paper we want to present a case of bronchogenic cyst with continuous intrauterine cyst aspiration
follow-up. After the baby birth was operated and the postoperative period was uneventful. The pathological examination revealed
a bronchogenic cyst.
1.Introduction
Congenital lung pathology is uncommon but mostly life-
threatening malformations and needs urgent surgery [1, 2],
and commonly these malformations share similar embry-
ologic and clinical characteristics [3]. The experience with
antenatal detected cystic lung lesions was deﬁnitely limited,
consisting of case reports [4–6].
It has been supposed that the removal of an intratho-
racic mass eﬀect may allow the development of enough
lung tissue to maintain postnatal survival. Thoracocentesis,
fetal thoracoamniotic shunts, and fetal surgery have been
used in human fetuses for this purpose [7–9]. Primary
hydrothoraces and congenital pulmonary cystic malfor-
mations are agreeable to such treatment. However, these
methods carry the potential risks of a procedure-associated
morbidity and mortality [10] Presently, there is no com-
bined professional agreement on inutero treatment for these
conditions.
In this case, intrauterine pulmonary drainage for the
management of a congenital bronchogenic pulmonary cyst
diagnosed at the 24th gestational week was reported.
2.CaseReport
A 25-year-old primigravida woman was referred for further
investigation at the 24 weeks’ gestation because of congenital
cystic lung lesion. A review of the history revealed that
the parents were both healthy. The mother did not report
any past history of medical problems or recent infectious
episodes. In addition, she had no exposure to teratogenic
agents such as drugs, tobacco, or alcohol. The family history
was also noncontributory. A level II sonographic exami-
nation revealed uniloculated, 40 × 37mm sized, smooth
contour congenital cystic lung lesion which originated from
left hemi thorax with mediastinal shift causing decrease in
lung volume (Figure 1). The other organs were revealed
as normal. After discussion with the family about possible
outcomes pregnancy was continued. The pediatric surgical
team was occupied after the conﬁrmation of an antenatal
diagnosed cystic lung disease to assist with antenatal coun-
seling and postnatal management.
After discussion, inutero drainage of the cyst was decided
and a written permission form was taken from the family.





Figure 1: Sonographic examination revealed uniloculated, 40 ×
37mm sized, smooth contour congenital cystic lung lesion which















Figure 2: Sonographic examination of congenital cystic lung lesion
after thoracocentesis.





Figure 3: CT imaging of the ballooning of the cyst after birth.
Figure 4: Roentgen imaging of the lungs after birth.
gestational weeks (Figure 2). We made the procedure with
sonographic guidance(LOGIQ 7 scanner GE medical system,
Milwaukee, WI). Cyst was aspirated with 20GA amniocen-
tesis needle (Becton, Dickinson and Company, BD, USA).
Genetic and histological analyses were made for cystic ﬂuid.
Genetic analysis was normal (46, XX). Histological analysis
was reported as erythrocytes and degenerated epithelial cells.
At 24th gestational week, cyst/thorax rate was 3/8, after the
30thgestationalweek,thisratewasdecreasedto1/10.Steroid
was given for lung maturation. After the 30th gestational
week, the diameter of cyst was stabilized at 20 × 17mm and
mediastinal shift disappeared and the patient was follow-up
to the birth every two weeks. Hydrops was not observed in
inutero life. At the 39th gestational week, the female baby
was born without any complication. Patient was operated
due to overexpansion of the cyst at the postpartum forth day
(Figures 3 and 4). After operation, the baby was discharged
without any complication. The histological examination of
the cyst was reported as bronchogenic cyst (cysts which
were laid down with ciliated respiratory epithelium at the
inner side and contained focal cartilaginous structures at the
ﬁbrous wall). She was 7 months old and healthy at the time
of writing.
3. Discussion
Recent developments of ultrasonography increase the diag-
nosis of congenital cystic lung lesions. The progression
and natural history of congenital cystic lung lesions is
inadequately understood. The spectrum of presentation of
cystic lung lesions ranges from fetal hydrops and stillbirth, to
neonatal respiratory distress, to asymptomatic lesions. But
antenatally diagnosed asymptomatic cystic lung lesions can
be present later in life with either respiratory problems or
malignancy, or as sudden death [11–13].
These cysts may result from compromised interaction
between embryologic mesodermal and ectodermal lung
components during development. Pulmonary sequestration,
congenital cystic adenomatoid malformation (CCAM), con-
genital lobar emphysema, and bronchogenic pulmonaryCase Reports in Medicine 3
cysts are the main four congenital cystic lesions in the lung,
butsharesimilarembryologicandclinicalcharacteristics[2].
These pathologies may compromise the prenatal devel-
opment of functioning parenchymal lung tissue. Conse-
quently, pulmonary hypoplasia may develop and lead to
signiﬁcant perinatal morbidity and mortality at birth. Also,
fetal hydrops fetalis and polyhydramnios may develop and
the risk of prematurity, furthering the risk of perinatal loss,
increases.
Bronchogenic pulmonary cysts were one of the most
commonlesion,and,commonlyoccurearlyinlungdevelop-
ment [3]. Bronchogenic cysts might accurately be called lung
bud cysts, since they possibly originated from embryonic
bud tissue before the bronchi appeared. The cyst is mostly
laid down with ciliated columnar epithelium and contain
cartilaginous, smooth muscle tissue, glandular structures,
and sometimes mucosa of esophagus and stomach [3].
Bronchogenic cysts need urgent surgery at a rate of 33.3%
[14]. Asymptomatic bronchogenic cysts,operated nearly 5-7
years old are commonly complicated with repeated infection
and cough but none shows respiratory distress.
Percutaneous, inutero pulmonary drainage in fetuses
with ultrasonographic evidence of congenital pulmonary
cystic malformations is associated with improved perinatal
survival [10]. Inutero pulmonary drainage has been used for
many years but no combined treatment consensus has been
accomplished. Elective excisional surgery recommended for
those infants and children with symptoms, evidence of
mediastinal shift, diagnostic doubt, and involvement of a
signiﬁcant part of the lung (>25% of ipsilateral lung, as
assessed on CT scan) [12]. Lung preserving surgery is
promising only if undertaken electively before any infective
complication in antenatally diagnosed thoracic lesions [13].
At postnatal period, as a conclusion prenatal recognition
of these relatively rare congenital cystic lung lesions would
lead to the immediate, proper surgical intervention and the
need for surgery should be based on appropriate postnatal
investigations, rather than antenatal behavior. This approach
should retrieve almost all the aﬀected cases, which would
otherwise face a rather dismal future.
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